Latest stories on OMER
What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?
Quartz57 · neutralgeneral
Omeros (OMER) Q2 2026 Earnings Call Transcript
Yahoo Finance50 · neutralearnings
Omeros (OMER) Q2 2026 Earnings Call Transcript
The Motley Fool50 · neutralearnings
Omeros options imply 9.8% move in share price post-earnings
The Fly56 · neutralearnings
Omeros reports Q2 adjusted EPS 2c vs (24c) last year
The Fly58 · neutralearnings
Omeros: YARTEMLEA Is Off To A Blistering Start
Seeking Alpha73 · bullishproduct/pr
Omeros Appoints Veteran Investor Joseph Schocken to Board
TipRanks55 · neutralgeneral
OMEROS CORP (OMER) files 8-K
SEC 8-K50 · neutralgeneral
Top trending stocks today: ARX, OMER, TMS lead the market movers
Investing.com Markets50 · neutralgeneral
Surging YARTEMLEA Revenues and Bold Debt Reduction Mark Omeros’ Transformative Quarter
August 13, 2026
MarketChameleon73 · bullishearnings
This Biotech Stock Just Gapped Up To A Five-Year High; Here's Why
Investors.com73 · bullishearnings
Omeros surges on Q2 beats
Seeking Alpha73 · bullishearnings
Omeros Shares Climb on Swing to 2Q Profit, Higher Revenue
MarketWatch67 · bullishearnings
Why is Omeros stock surging today?
Investing.com Markets50 · neutralgeneral
Omeros outlines Q3 2026 interest expense of about $6.5M while advancing $287,000 NTAP for YARTEMLEA
Seeking Alpha56 · neutralearnings
Omeros Corporation (OMER) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Omeros Corporation Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
OMER Stock Soars 24% After-Hours On YARTEMLEA Sales Momentum, Debt Reduction And Share Buybacks
Stocktwits News71 · bullishproduct/pr
OMEROS CORP (OMER) files 8-K
SEC 8-K50 · neutralgeneral
Omeros Non-GAAP EPS of $0.02 beats by $0.35, revenue of $28.53M beats by $15.86M
Seeking Alpha68 · bullishearnings
Omeros Corporation Reports Second Quarter 2026 Financial Results
StockTitan50 · neutralearnings
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
StockTitan50 · neutralearnings
OMER Stock Gains 4% — CMS Green-Lights $287K Add-On Payments For Transplant Drug
Stocktwits News63 · neutralproduct/pr
CMS Grants NTAP Status to YARTEMLEA, Simplifying Medicare Access for Omeros’ Groundbreaking TA-TMA Therapy
August 3, 2026
MarketChameleon73 · bullishproduct/pr
AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights
Stocktwits News58 · neutralanalyst